Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Cell Transplantation
86%
Hematopoietic Cell
86%
Acute Graft Versus Host Disease
72%
Graft-Versus-Host Disease
60%
Mesenchymal Stem Cell
56%
T Cell
43%
Bone Marrow Transplantation
42%
Allogeneic Stem Cell Transplantation
42%
Overall Survival
41%
Regulatory T Cell
40%
Immune Reconstitution
38%
Allogeneic Peripheral Blood Stem Cell Transplantation
28%
Chronic Graft Versus Host Disease
24%
Hematopoietic Stem Cell Transplantation
23%
Anti-Thymocyte Globulin
21%
Survival Rate
21%
CD34
20%
Infection
19%
Infectious Disease
19%
Stem Cell
17%
Mouse Model
15%
Humanized Mouse
15%
Influenza
14%
Immune System
14%
Cyclophosphamide
14%
Coagulase Negative Staphylococcus
14%
Globulin
14%
Allograft
14%
Antibody Response
14%
Neutralizing Antibody
14%
CXCR4
14%
Long Term Survival
14%
Cell Metabolism
14%
Chimeric Antigen Receptor T-Cell
14%
BK Virus
14%
Steroid
14%
Progression Free Survival
13%
CD3 Antigen
11%
Graft Versus Tumor Effect
9%
Immunosuppressive Therapy
9%
Magnetic Resonance Imaging
9%
Peripheral Blood Stem Cell Transplantation
9%
Antimicrobial Agent
9%
Immunocompetent Cell
9%
In Vitro
8%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Receptor Binding
7%
Normal Value
7%
Arm
7%
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
74%
Chronic Graft-versus-host Disease (cGVHD)
51%
Graft-versus-host Disease (GvHD)
44%
SFGM-TC
14%
Transplantation Therapy
14%
EEG Characteristics
14%
CNS Manifestations
14%
HLA-mismatched Unrelated Donor
14%
Double-blind Randomized Study
14%
Co-infusion
14%
Lymphoid Progenitors
14%
Committed Progenitors
14%
Mesenchymal Stromal Cells
14%
C-X-C Chemokine Receptor Type 4 (CXCR4)
14%
Francophone
14%
Elderly Patients
14%
Bone Marrow Transplantation
14%
Post-transplant Cyclophosphamide (PTCy)
14%
Terminally Differentiated
14%
Acute Myeloid Leukemia
14%
Reduced-intensity Conditioning
14%
Transplanted Patients
14%
Matched Unrelated Donor
14%
Chimeric Antigen Receptor T Cells (CAR-T)
14%
Hematological Malignancies
14%
Treg
14%
Cellular Metabolism
14%
Multipotent Stromal Cells
14%
Cell Therapy
14%
Immunomonitoring
14%
Venous Access Device
14%
Transplantation Study
14%
Central Nervous System
14%
Cutaneous Lymphoma
14%
Regulatory T Cells
14%
CD24
13%
CD34+
13%
Umbilical Cord-derived Mesenchymal Stromal Cells
9%
Immune Reconstitution
9%
Transplantation
8%
CD10
8%
Bone Marrow
8%
Overall Survival
7%
Ineligibility
7%
Interleukin-2
6%
T Cell Differentiation
5%
Gene Expression
5%
Medicine and Dentistry
Bone Marrow Transplantation
28%
Allogeneic Stem Cell Transplantation
28%
Overall Survival
26%
Hematopoietic Cell
20%
Cell Transplantation
20%
Stem Cell
17%
Diseases
16%
Survival Rate
14%
Cell Therapy
14%
Cutaneous Lymphoma
14%
Cutaneous T Cell Lymphoma
14%
Pyrrole
14%
Invasive Aspergillosis
14%
Hemorrhagic Cystitis
14%
BK Virus
14%
Cidofovir
14%
Oral
14%
Intensive Care
14%
SOFA Score
14%
Allograft
14%
Allogeneic Peripheral Blood Stem Cell Transplantation
14%
Hazard Ratio
14%
Prognostic Factor
14%
Long Term Survival
14%
Mycosis fungoides
11%
Progression Free Survival
11%
Combination Therapy
9%
Intensive Care Unit
8%
Allogeneic Hematopoietic Stem Cell Transplantation
8%
Multivariate Analysis
8%
CD3 Antigen
7%
Thymocyte Antibody
5%
Morbidity
5%